Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Eculizumab in atypical hemolytic-uremic syndrome.

Tanimoto T, Oshima Y, Kami M.

N Engl J Med. 2013 Oct 3;369(14):1378-9. doi: 10.1056/NEJMc1308826. No abstract available.

PMID:
24088109
2.

Eculizumab in atypical hemolytic-uremic syndrome.

Kistler AD.

N Engl J Med. 2013 Oct 3;369(14):1378. doi: 10.1056/NEJMc1308826. No abstract available.

3.

Eculizumab in atypical hemolytic-uremic syndrome.

Amadio A, Tejani AM.

N Engl J Med. 2013 Oct 3;369(14):1378. doi: 10.1056/NEJMc1308826. No abstract available.

PMID:
24088107
4.

Eculizumab in atypical hemolytic-uremic syndrome.

Ring T.

N Engl J Med. 2013 Oct 3;369(14):1377-8. doi: 10.1056/NEJMc1308826. No abstract available.

PMID:
24088106
5.

Eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Loirat C.

N Engl J Med. 2013 Oct 3;369(14):1379-80. doi: 10.1056/NEJMc1308826. No abstract available.

PMID:
24088105
6.

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.

N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.

7.

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

Zimmerhackl LB, Hofer J, Cortina G, Mark W, Würzner R, Jungraithmayr TC, Khursigara G, Kliche KO, Radauer W.

N Engl J Med. 2010 May 6;362(18):1746-8. doi: 10.1056/NEJMc1001060. No abstract available.

PMID:
20445192
8.

More on eculizumab for congenital atypical hemolytic-uremic syndrome.

Shin JI, Lee JS.

N Engl J Med. 2009 May 14;360(20):2142-3; author reply 2143. doi: 10.1056/NEJMc090453. No abstract available.

PMID:
19439754
9.

Eculizumab for congenital atypical hemolytic-uremic syndrome.

Gruppo RA, Rother RP.

N Engl J Med. 2009 Jan 29;360(5):544-6. doi: 10.1056/NEJMc0809959. No abstract available.

PMID:
19179329
10.

Eculizumab for atypical hemolytic-uremic syndrome.

Nürnberger J, Philipp T, Witzke O, Opazo Saez A, Vester U, Baba HA, Kribben A, Zimmerhackl LB, Janecke AR, Nagel M, Kirschfink M.

N Engl J Med. 2009 Jan 29;360(5):542-4. doi: 10.1056/NEJMc0808527. No abstract available. Erratum in: N Engl J Med. 2009 Jun 4;360(23):2487. Philipp, Thomas [added].

PMID:
19179328

Supplemental Content

Loading ...
Support Center